))
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
…
continue reading
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
…
continue reading
1
Clinical Pearls for Selecting the Right Benzodiazepine
11:54
11:54
Spill senere
Spill senere
Lister
Lik
Likt
11:54
In this episode, we discuss the appropriate use of benzodiazepines, focusing on evidence-based indications and optimal medication selection. Did you know that alprazolam has unique properties that make it more addictive than other benzodiazepines? Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CM…
…
continue reading
1
TMS for Depression: From Clinical Trials to Results
16:27
16:27
Spill senere
Spill senere
Lister
Lik
Likt
16:27
In this episode, we explore the evidence behind Transcranial Magnetic Stimulation (TMS) for depression, from early clinical trials to real-world effectiveness. What makes some patients respond better to TMS than others? We discuss response rates, treatment protocols, and the exciting development of faster treatment options. Faculty: Simon Kung, M.D…
…
continue reading
In this episode, we explore the crucial aspects of patient selection for Transcranial Magnetic Stimulation (TMS) in treating depression. We discuss insurance criteria, contraindications, and practical considerations. Did you know that while TMS was FDA-approved in 2008, it wasn't widely accessible until Medicare began covering it in 2014? Faculty: …
…
continue reading
1
Rethinking Clozapine Monitoring: 22 Years of Data
13:07
13:07
Spill senere
Spill senere
Lister
Lik
Likt
13:07
In this episode, we explore a landmark Finnish study examining the long-term risk of agranulocytosis in patients taking clozapine. The research followed 62,000 patients over 22 years, providing crucial data about this rare but serious side effect. Could these findings change how we approach clozapine prescribing and monitoring requirements? Faculty…
…
continue reading
1
Understanding TMS in OCD: Evidence and Practice
8:32
8:32
Spill senere
Spill senere
Lister
Lik
Likt
8:32
In this episode, we explore Transcranial Magnetic Stimulation (TMS) as a treatment option for Obsessive-Compulsive Disorder (OCD). We discuss the FDA-approved devices, unique protocols, and why patients need their anxiety triggered before each session. Did you know TMS for OCD targets a completely different brain region than TMS for depression? Fac…
…
continue reading
1
Breaking Down the TRAILBLAZER-ALZ 2 Trial
10:27
10:27
Spill senere
Spill senere
Lister
Lik
Likt
10:27
In this episode, we explore donanemab, a groundbreaking monoclonal antibody treatment for Alzheimer's disease. We discuss its efficacy in reducing beta-amyloid plaques, unique treatment duration protocol, and safety considerations. Could this time-limited treatment approach revolutionize how we manage Alzheimer's progression? Faculty: Scott Beach, …
…
continue reading
1
Long-term Benzo Use: What The Data Really Show
10:58
10:58
Spill senere
Spill senere
Lister
Lik
Likt
10:58
In this episode, we explore a groundbreaking Danish registry study that challenges common beliefs about long-term benzodiazepine use and dose escalation patterns. Are our concerns about inevitable tolerance and dependence justified? The study's findings might surprise you and reshape prescribing practices. Faculty: Scott Beach, M.D. Host: Richard S…
…
continue reading
1
Navigating TMS Side Effects: A Practical Guide
8:05
8:05
Spill senere
Spill senere
Lister
Lik
Likt
8:05
In this episode, we explore the side effects and safety considerations of Transcranial Magnetic Stimulation (TMS) therapy in psychiatry. Did you know that despite common concerns, fewer than 2% of patients discontinue TMS due to discomfort? We'll discuss everything from common side effects to practical management strategies. Faculty: Simon Kung, M.…
…
continue reading
1
SSRIs and Anticoagulants: Navigating Bleeding Risk
11:06
11:06
Spill senere
Spill senere
Lister
Lik
Likt
11:06
In this episode, we explore the crucial interaction between SSRIs and oral anticoagulants, examining a groundbreaking 23-year study of over 330,000 patients. Does combining these medications significantly increase bleeding risk, and if so, how can we safely manage patients who need both treatments? Faculty: Scott Beach, M.D. Host: Richard Seeber, M…
…
continue reading
1
Lamotrigine and the Heart: What You Need to Know
7:38
7:38
Spill senere
Spill senere
Lister
Lik
Likt
7:38
In this episode, we explore the safe use and monitoring of lamotrigine, focusing on cardiac risks and when EKG monitoring is necessary. Did you know that reducing lamotrigine dose doesn't actually mitigate cardiac risks but could increase the risk of psychiatric destabilization? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about…
…
continue reading
1
After the Last Dose: Understanding Antipsychotic Discontinuation
11:27
11:27
Spill senere
Spill senere
Lister
Lik
Likt
11:27
In this episode, we explore the often-overlooked phenomenon of antipsychotic withdrawal, examining new findings from the world's largest drug safety database. Could some cases of apparent psychotic relapse actually be withdrawal symptoms in disguise? We discuss common withdrawal effects, risk factors, and evidence-based strategies for safe medicati…
…
continue reading
1
Understanding Lamotrigine's Cardiac Effects
7:38
7:38
Spill senere
Spill senere
Lister
Lik
Likt
7:38
In this episode, we explore lamotrigine's cardiac side effects, focusing on QTc prolongation and QRS widening. How concerned should psychiatrists be about the FDA warning regarding lamotrigine's cardiac effects? We examine the evidence behind these concerns and discuss practical implications for clinical practice. Faculty: Scott Beach, M.D. Host: R…
…
continue reading
1
Rethinking Falls: Are Sleep Medications Really to Blame?
12:09
12:09
Spill senere
Spill senere
Lister
Lik
Likt
12:09
In this episode, we examine a groundbreaking Danish study that challenges the conventional belief that sedative medications increase fall risk in older adults. Could untreated insomnia, rather than the medications used to treat it, be the real culprit behind falls in elderly patients? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more…
…
continue reading
